Activa Deep-Brain Stimulation Coverage Includes Provider, Facility Criteria

CMS will monitor results of two long-term clinical studies evaluating "optimal targeting" for deep-brain stimulation to treat Parkinson's disease and essential tremor, following a positive national coverage determination